<DOC>
	<DOCNO>NCT01177670</DOCNO>
	<brief_summary>The Adiana Post-Approval Clinical Study ( APACS ) design compile information efficacy safety Adiana Permanent Contraception System post market set . Specifically , data collect relevant evaluation safety efficacy Adiana System woman desire permanent birth control occlusion fallopian tube . This study observational study intend test specific hypothesis .</brief_summary>
	<brief_title>Adiana Post-Approval Clinical Study ( APACS )</brief_title>
	<detailed_description>Adiana Post-Approval Clinical Study prospective , single arm , multi-center , observational study design provide additional efficacy safety data regard FDA-approved Adiana Permanent Contraception System . This study conduct 8-10 clinical site enroll 1000 subject . Enrolled subject baseline data collect time Adiana procedure follow period 2 year visit occur 3 month follow Adiana procedure , 6 month follow Adiana procedure ( applicable ) , 12 24 month post rely date .</detailed_description>
	<criteria>Subjects seek permanent sterilization Women 1845 year old Subjects risk become pregnant Subjects willing use alternative contraception least three ( 3 ) month follow device placement bilateral tubal occlusion confirm HSG Subjects able provide inform consent Subjects uncertain desire end fertility Clinical evidence active pelvic infection history recent pelvic infection Has intrauterine pathology would prevent access either tubal ostium intramural portion either fallopian tube ( i.e. , large submucous fibroid , uterine adhesion , apparent uni bilateral proximal tubal occlusion , suspect unicornuate uterus , etc . ) Is pregnant ( evidenced pregnancy test result ) suspect pregnancy Is currently less three ( 3 ) month since last pregnancy Has previously undergone tubal ligation Is currently take immunosuppressive medication ( e.g. , steroid ) Has know allergy contrast medium Has external pacemaker internal cardioverter defibrillator Subject unable follow protocol return follow visit In opinion investigator , subject medical condition precludes safe participation study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Adiana Permanent Contraception System</keyword>
	<keyword>woman seek permanent sterilization .</keyword>
</DOC>